Eight Great Technologies

The name derives from a 2013 UK government policy paper identifying eight 'great technologies' where Britain could achieve global scientific leadership. The firm adopted this framework as its fixed investment universe, committing capital only to companies operating in those eight fields: big data, space, robotics, synthetic biology, regenerative medicine, agri-science, advanced materials, and energy storage. This link to national industrial strategy is a public-record feature of the firm's identity.

The firm does not disclose a weighting across the eight sectors. However, given the concentration of UK and European scientific funding, robotics and autonomous systems, synthetic biology, and energy storage are likely areas of densest deal flow. The firm invests across the full set as opportunities arise, without publicly reported sector exclusions within the eight.

The firm's publicly understood model centers on direct equity investments in operating companies within the eight technology areas. There is no public record of Eight Great Technologies acting as a fund-of-funds or making LP commitments to other managers. Its investment activity appears structured entirely around direct venture and growth-stage positions.

Eight Great Technologies invests primarily in the United Kingdom and continental Europe, with a focus on companies emerging from government-backed research programs, university spin-outs, and national science infrastructures. There is no public indication of investment activity in North America or Asia. The geographic footprint aligns with the UK-centric origin of the eight technologies framework.

The firm's principals and investment committee have not been publicly identified in available records. Eight Great Technologies maintains a low public profile relative to peer deep-tech investors, and no named partners or managing directors appear in standard corporate registries or press reporting tied to the firm's investment activity.